Delivery Order SPE2DB20D3103-SPE2DB25FP2Y4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,097.08 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 mL vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Docetaxel 80 mg/4 mL vials valued at $1,093.69. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,041.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Docetaxel 160 mg/16 ml vials on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive set-aside delivery order represents a pharmaceutical supply transaction fulfilling military healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- This is a $7,315.20 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 160 mg/16 ml vials of the cancer medication docetaxel. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,574.73 for Docetaxel 160 mg/16 mL vials on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Docetaxel is a chemotherapy medication used primarily in cancer treatment protocols across military and federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,387.22, is for the supply of 4,564,688,768 mL of the pharmaceutical product Docetaxel 160 mg/16 mL. The order has a firm fixed-price pricing type and a completion date of May 23, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,975,167 units of Docetaxel 80 mg/4 ml vial 4 ml, a specialty medication. The contract has a firm fixed price of $1,317.74 and a completion date of January 21, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,761.82 delivery order to Amerisourcebergen Drug Corp for the supply of 4562082718, described as DOCETAXEL 80 MG/8 ML VIAL 8ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania under firm fixed pricing within the period of performance of September 7-8, 2023. The parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $149,340 to Amerisourcebergen Drug Corporation to supply docetaxel, an oncology drug, for one day's performance in Conshohocken, Pennsylvania. As a prime contractor on the Defense Logistics Agency's Prime Vendor program, which covers pharmaceuticals and other medical commodities for the Department of Defense, Amerisourcebergen will deliver the chemotherapy medication from its distribution center to support DOD...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Paclitaxel 300 mg/50 ml vials with a firm fixed price ceiling value of $1,126.20. This delivery order represents a non-set-aside, competitively awarded procurement supporting the federal government's pharmaceutical supply requirements. The award is fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP2Y4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Docetaxel 160 mg/16 ml vials, with a ceiling value of $6,528.00. This competitive, non-set-aside award was issued on June 25, 2025, with an ultimate completion date of June 26, 2025, and reflects a firm fixed-price arrangement. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio encompasses a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, specialty drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Docetaxel, an oncology medication, represents one of numerous competitive awards the contractor fulfills under its prime vendor agreement to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 6/25/25 |